Impact of Andropause on Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Endocrinology
• Aging Research

Background:

• Andropause is characterized by a gradual decline in testosterone levels due to aging, affecting the hypothalamic-pituitary-gonadal axis and testicular function.
• Emerging evidence suggests a correlation between lower testosterone levels and an increased risk of Multiple Sclerosis (MS).
• MS onset typically occurs later in men than women, potentially linked to declining protective testosterone levels.

Purpose of the Study:

• To review the role of androgens in the development and function of innate and adaptive immune responses.
• To examine androgen involvement in neuroprotective mechanisms relevant to Multiple Sclerosis.
• To discuss testosterone's effects on physical disability and cognitive function, supported by animal and human studies.

Main Methods:

• Review of existing scientific literature, including animal models and epidemiological studies in humans.
• Analysis of testosterone's impact on immune responses and neuroprotection.
• Examination of clinical trials investigating androgen therapy in relation to MS.

Main Results:

• Androgens play a role in modulating both innate and adaptive immunity.
• Testosterone exhibits neuroprotective effects relevant to Multiple Sclerosis.
• Studies indicate correlations between testosterone levels, physical disability, and cognitive function in MS patients.

Conclusions:

• Androgens are implicated in immune regulation and neuroprotection, suggesting a potential link between andropause and MS.
• Further research and clinical trials are warranted to explore androgen therapy for MS management.
• Understanding the role of androgens, especially during sexual maturation, may offer new therapeutic avenues for MS.